INB-619 precisely targets and eliminates B cells from lupus patient samples, including harmful IgG1 and IgM antibodies, ...

IGM Biosciences, Inc. (IGMS) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.83 per share a year ago. These ...

And Red River College Polytechnic (RRC Polytech) today announced the inaugural 10 recipients of the IG Empower Your Tomorrow Indigenous Scholarship. The 2025 scholarship includes $12,000 in financial ...

IGM Financial Inc. ( TSE:IGM ) has announced that it will pay a dividend of CA$0.5625 per share on the 31st of ...

A double-digit conglomerate discount makes Power Corporation of Canada (TSX:POW) an attractive dividend-growth stock right ...

The Episcopal Church’s migration service is refusing a directive from the U.S. federal government to help resettle white ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Sales started to slow in the spring, as market uncertainty began to weigh on investor confidence, says CEO James O’Sullivan ...

US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...

Detailed price information for Igm Financial Inc (IGIFF) from The Globe and Mail including charting and trades.

IGM Financial Inc (IGIFF) reports record earnings and significant asset growth, while navigating market volatility and strategic challenges.